Effect of direct acting antiviral treatment (DAAs), as a new treatment of chronic viral hepatitis C on patients with heart failure

Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients

SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS

ASSESSMENT OF CARDIAC FUNCTIONS IN EGYPTIAN CHRONIC HEPATITIS C PATIENTS BEFORE AND AFTER TREATMENT WITH DIRECTLY ACTING ANTIVIRALS

Assessment of Haematological and Immunological Effect after New Direct ‎Acting Antiviral Drugs in Chronic Hepatitis C Virus Egyptian Patients

TYPES AND PREDICTORS OF INTERFERON/RIBAVIRIN INDUCED CARDIAC COMPLICATIONS IN THE EGYPTIAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS

Safety & Efficacy of Direct Acting Antiviral (Sofosbuvir & Daclatasvir) in Treatment of Chronic HCV in HIV-HCV Co-Infected Egyptian Patients

IMPACT OF TREATMENT WITH DIRECT ACTING ANTIVIRAL AGENTS (DAAS) ON MIXED CRYOGLOBULINEMIA OF HCV EGYPTIAN PATIENTS

EVALUATION OF DIRECT ACTING ANTIVIRAL AGENTS IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION IN ALEXANDRIA

HCC Incidence in DAAs-Treated and Untreated Egyptian HCV-Infected Patients